Vistagen Therapeutics's top three insider shareholders as of August 04, 2026 are Healthcare Capital Partners Ii, L.P. Venrock (TenPercentOwner, 20.64Mn shares), Capital Lp Commodore (TenPercentOwner, 1.57Mn shares), Shawn Singh (Chief Executive Officer, 626.23K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Jerry B Gin | - | 100,000 | 100,000 | 22 Aug, 2022 |
| Jerrold Duane Dotson | Vp, Cfo | 3,671 | 0 | 05 Jul, 2023 |
| Shawn Singh | Chief Executive Officer | 0 | 626,234 | 18 Aug, 2022 |
| H. Ralph Snodgrass | Pres./Chief Scientific Officer | 64,958 | 0 | 03 Jan, 2022 |
| Healthcare Capital Partners Ii, L.P. Venrock | - | 0 | 20,637,286 | 14 Jul, 2022 |
| Mark Alan Smith | Chief Medical Officer | 19,915 | 0 | 15 Jul, 2022 |
| Capital Lp Commodore | - | 0 | 1,575,000 | 09 Aug, 2023 |
| Reid G. Adler | Chief Legal Officer | 24,050 | 0 | 01 Jul, 2025 |
| Cynthia Lynn Anderson | Chief Financial Officer | 12,801 | 0 | 01 Jul, 2025 |
| Joshua S. Prince | Chief Operating Officer | 15,249 | 0 | 05 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 07 Apr, 2026 | Reid G. Adler | Incentive Stock Option (right to buy) | A | 18,753 | $0.00 | 18,753 | D | A |
| 07 Apr, 2026 | Joshua S. Prince | Incentive Stock Option (right to buy) | A | 18,752 | $0.00 | 18,752 | D | A |
| 07 Apr, 2026 | Nick B. Tressler | Incentive Stock Option (right to buy) | A | 75,000 | $0.00 | 75,000 | D | A |
| 07 Apr, 2026 | Shawn Singh | Incentive Stock Option (right to buy) | A | 3,732 | $0.00 | 3,732 | D | A |
| 07 Apr, 2026 | Reid G. Adler | Non-Qualified Stock Option (right to buy) | A | 56,247 | $0.00 | 56,247 | D | A |
| 07 Apr, 2026 | Joshua S. Prince | Non-Qualified Stock Option (right to buy) | A | 56,248 | $0.00 | 56,248 | D | A |
| 07 Apr, 2026 | Shawn Singh | Non-Qualified Stock Option (right to buy) | A | 71,268 | $0.00 | 71,268 | D | A |
| 31 Dec, 2025 | Joshua S. Prince | Common Stock | A | 4,386 | $0.56 | 15,249 | D | A |
| 01 Dec, 2025 | Nick B. Tressler | Common Stock (Right to Buy) | A | 150,000 | - | 150,000 | D | A |
| 27 Oct, 2025 | Paul R Edick | Stock Option (Right to Buy) | A | 35,200 | - | 35,200 | D | A |
| 09 Sep, 2025 | Ann Michelle Cunningham | Non-Qualified Stock Option (right to buy) | A | 17,600 | $0.00 | 17,600 | D | A |
| 09 Sep, 2025 | Margaret M Fitzpatrick | Non-Qualified Stock Option (right to buy) | A | 17,600 | $0.00 | 17,600 | D | A |
| 09 Sep, 2025 | Joanne Curley | Non-Qualified Stock Option (right to buy) | A | 17,600 | $0.00 | 17,600 | D | A |
| 09 Sep, 2025 | Jon S Saxe | Non-Qualified Stock Option (right to buy) | A | 17,600 | $0.00 | 17,600 | D | A |
| 09 Sep, 2025 | Mary L. Rotunno | Non-Qualified Stock Option (right to buy) | A | 17,600 | $0.00 | 17,600 | D | A |
| 30 Jun, 2025 | Shawn Singh | Common Stock | A | 7,541 | $1.70 | 18,028 | D | A |
| 30 Jun, 2025 | Cynthia Lynn Anderson | Common Stock | A | 6,617 | $1.70 | 12,801 | D | A |
| 30 Jun, 2025 | Reid G. Adler | Common Stock | A | 7,541 | $1.70 | 24,050 | D | A |
| 30 Jun, 2025 | Joshua S. Prince | Common Stock | A | 4,882 | $1.70 | 10,863 | D | A |
| 23 Jun, 2025 | Reid G. Adler | Stock Option (Right to Buy) | A | 100,000 | $0.00 | 100,000 | D | A |